PLXP - ディペクシウム・ファ―マシュ―ティカルズ (PLx Pharma Inc.)

PLXPのニュース

   Insider Buys PLx Pharma Stock  2020/08/24 11:33:00 Benzinga
A Form 4 filing filed with the SEC on Monday, August 24 showed that OConnor Rita M bought 2,300 shares of PLx Pharma Inc. (NASDAQ: PLXP) at $3.77 on …
   PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14, 2020 Conference Call and Provide Business Update  2020/08/05 20:30:00 GlobeNewswire
SPARTA, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .
   Insider Buys PLx Pharma Stock  2020/08/24 11:33:00 Benzinga
A Form 4 filing filed with the SEC on Monday, August 24 showed that OConnor Rita M bought 2,300 shares of PLx Pharma Inc. (NASDAQ: PLXP) at $3.77 on …
   PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14, 2020 Conference Call and Provide Business Update  2020/08/05 20:30:00 GlobeNewswire
SPARTA, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .
   Insider Buys PLx Pharma Stock  2020/08/24 11:33:00 Benzinga
A Form 4 filing filed with the SEC on Monday, August 24 showed that OConnor Rita M bought 2,300 shares of PLx Pharma Inc. (NASDAQ: PLXP) at $3.77 on …
   PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14, 2020 Conference Call and Provide Business Update  2020/08/05 20:30:00 GlobeNewswire
SPARTA, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .

calendar